Is There Medicine for Overthinking and Anxiety?

Several categories of prescription medication can treat the kind of repetitive, unproductive thinking most people call “overthinking,” especially when it occurs alongside anxiety. Overthinking is not a formal diagnosis on its own, but the clinical term for it, rumination, is recognized as a feature that cuts across depression, generalized anxiety disorder, and other conditions.¹ Because overthinking and anxiety share overlapping brain circuits, medications developed for anxiety disorders frequently quiet rumination too. The real question is which type of medication fits your situation, what to realistically expect, and what else you should know before starting.

What Happens in the Brain When You Overthink

Your brain has a network of regions that activate when you are not focused on any particular task. Researchers call it the default mode network, and it handles things like self-reflection, imagining the future, and replaying past events. In people with generalized anxiety disorder, parts of this network show heightened activity compared to healthy controls. A 2023 neuroimaging study found that specific areas within the default mode network, including the left angular gyrus and medial prefrontal cortex, were significantly more active in people with generalized anxiety disorder than in those with other anxiety conditions or no anxiety at all. The strength of this overactivity correlated with the severity of anxiety symptoms.²

Think of it this way: in someone without anxiety, the default mode network hums along quietly when the brain is idle, maybe daydreaming or loosely planning dinner. In someone with anxiety-driven overthinking, that same network runs hot, cycling through worries, what-ifs, and self-critical replays with an intensity that feels impossible to interrupt. This is why medications that dampen excitatory signaling or boost calming neurotransmitters can help. They are not sedating the person into indifference; they are turning down a circuit that is stuck in overdrive.

SSRIs and SNRIs Are the Usual Starting Point

If you visit a doctor about persistent overthinking and anxiety, the first medication you’ll likely be offered is a selective serotonin reuptake inhibitor (SSRI) or a serotonin-norepinephrine reuptake inhibitor (SNRI). These are the same broad class of drugs used for depression, but they have robust evidence for anxiety as well. A Cochrane review covering 20 trials and over 7,200 participants found high-certainty evidence that antidepressants outperformed placebo for generalized anxiety disorder. For every seven people treated, one additional person experienced a meaningful response who would not have improved on placebo alone.³

Common SSRIs prescribed for anxiety include sertraline, escitalopram, and paroxetine. Common SNRIs include venlafaxine and duloxetine. A meta-analysis of 57 trials found no significant differences in effectiveness between individual drugs within each class or between SSRIs and SNRIs as groups.⁴ That means the choice often comes down to side-effect profile, your medical history, and what your doctor is most experienced prescribing. If one doesn’t work or causes intolerable side effects, switching to another in the same class is a standard and reasonable move.

One thing that surprises many people is the timeline. SSRIs and SNRIs are not fast-acting. Most people don’t feel meaningful relief for two to four weeks, and full benefit can take six to eight weeks. The same dose-response meta-analysis found that SNRIs tended to show their greatest early improvement in the first few weeks and then leveled off, while SSRIs improved more steadily across the treatment period.⁴ Either way, you should expect a slow ramp-up rather than overnight relief.

Buspirone, the Anxiety Drug Most People Haven’t Heard Of

Buspirone occupies an unusual niche. It’s FDA-approved specifically for generalized anxiety disorder, yet it gets far less public attention than SSRIs or benzodiazepines. It works through a different mechanism, acting on serotonin receptors rather than broadly boosting serotonin levels the way SSRIs do. Research has demonstrated that buspirone functions as both an anxiolytic and a panicolytic in clinical and animal studies.⁵ A systematic review and meta-analysis explored its side-effect profile and found evidence of cognitive benefits, which matters for people whose main complaint is foggy, looping thought.⁶

Buspirone has two big advantages over benzodiazepines: it carries essentially no risk of physical dependence, and it doesn’t cause the sedation or cognitive dulling that many people dislike about stronger anti-anxiety drugs. The trade-off is that, like SSRIs, it takes weeks to reach full effect. It also tends to work best for the chronic, low-grade worry that characterizes generalized anxiety rather than for acute panic episodes. If your overthinking is a constant background hum rather than an occasional crisis, buspirone may be a particularly good fit.

Benzodiazepines and Why Doctors Are Cautious

Benzodiazepines like alprazolam, lorazepam, and diazepam work fast. Within 30 to 60 minutes, they can dull the sharp edge of acute anxiety and interrupt a spiral of panicked thinking. They enhance the effect of a calming neurotransmitter in the brain, producing sedation, muscle relaxation, and a reduction in anxious mental chatter. For decades they were among the most commonly prescribed psychiatric medications, and they remain useful in specific situations: acute panic attacks, anxiety that needs immediate relief while waiting for an SSRI to kick in, or procedural anxiety before a medical event.

The reason most prescribers now treat them cautiously is the well-documented risk of dependence and cognitive effects with longer-term use. Clinical research has raised concerns about cognitive deficits associated with benzodiazepine abuse and dependence.⁷ With daily use over weeks to months, the brain adapts to the drug’s presence, and stopping suddenly can produce withdrawal symptoms that mimic or worsen the original anxiety. Most current guidelines recommend benzodiazepines only for short-term or as-needed use, not as a long-term solution for chronic overthinking. If your doctor prescribes one, it’s usually intended as a bridge while you wait for a longer-acting medication to start working.

Hydroxyzine, an Antihistamine That Doubles as an Anxiolytic

Hydroxyzine is technically an antihistamine, in the same drug family as allergy medications, but at the right dose it has genuine anti-anxiety effects. Controlled trials found that hydroxyzine at 50 mg was superior to placebo on all anxiety measures starting from the first week of treatment, with early improvement in the cognitive component of anxiety, meaning the worry and rumination side of things rather than just the physical symptoms. In a head-to-head trial against lorazepam, a benzodiazepine, hydroxyzine showed greater and more rapid cognitive improvement.⁸

Hydroxyzine is not habit-forming and doesn’t carry the dependence risk of benzodiazepines, which makes it appealing for people who need something beyond an SSRI but want to avoid controlled substances. The main downside is drowsiness. Because it acts on histamine receptors, it can make you sleepy, which is either a feature or a bug depending on whether your overthinking primarily strikes at night. Some clinicians prescribe it specifically for bedtime anxiety for that reason.

Beta-Blockers for the Physical Side of Anxiety

Propranolol and similar beta-blockers don’t directly treat the mental loop of overthinking. What they do is block the adrenaline-driven physical symptoms: racing heart, shaking hands, a quivering voice. Propranolol is one of the few medications with a strong track record for performance anxiety, sometimes called stage fright, because it crosses into the brain and has effects beyond simple heart-rate reduction.⁹

For some people, the physical symptoms of anxiety feed the mental spiral. Your heart races, you notice it, you start worrying about the racing heart, and the overthinking escalates. By cutting that physical feedback loop, a beta-blocker can indirectly calm the mind. They are typically taken as needed before a specific event rather than daily, and they are not appropriate for generalized, all-day rumination. If your overthinking flares in predictable situations like public speaking, meetings, or social events, a beta-blocker might handle it without the need for a daily psychiatric medication.

Off-Label Options Your Doctor Might Consider

When standard first-line medications don’t work well enough, clinicians sometimes turn to drugs approved for other conditions but studied for anxiety as well. Pregabalin and gabapentin, originally developed for seizures and nerve pain, work by inhibiting certain calcium channels in the brain, which reduces excitatory signaling.¹⁰ Pregabalin is approved for generalized anxiety disorder in several countries outside the United States and has an evidence base to support its use. Gabapentin has weaker anxiety-specific evidence but is sometimes tried when other options fail. Both can cause dizziness and sedation, and pregabalin carries some dependence risk at higher doses, so they’re generally reserved for cases where SSRIs, SNRIs, and buspirone haven’t been sufficient.

Ketamine is a more experimental option. It acts on a completely different receptor system and has attracted attention for its rapid effects on mood. A case report using ketamine-assisted psychotherapy for generalized anxiety disorder noted that the drug promotes neuroplasticity and has shown rapid, robust effects in mood and anxiety disorders.¹¹ However, the evidence for ketamine in anxiety specifically, as opposed to depression, is still thin. It is typically administered in clinical settings under supervision, and it remains far from a standard prescription for overthinking.

Supplements and Over-the-Counter Products

People frequently ask whether they can manage overthinking without a prescription, and a few supplements have at least some clinical evidence behind them. Silexan, a standardized lavender oil capsule, has been tested in multiple randomized, placebo-controlled trials. A meta-analysis found that after ten weeks of treatment, about 52% of participants taking Silexan met the criteria for treatment response, compared to about 39% on placebo. The overall effect was a roughly 2.9-point advantage on a standard anxiety scale.¹² That is a real but modest effect, smaller than what SSRIs typically produce. Silexan is available without prescription in many countries and may be worth trying for mild anxiety, though it’s unlikely to be enough for moderate to severe symptoms.

L-theanine, an amino acid found naturally in tea, has also generated interest. A placebo-controlled crossover study found that a single dose of L-theanine led to a significantly greater drop in salivary cortisol, a stress hormone, compared to placebo, and increased calming alpha brain-wave activity several hours after ingestion.¹³ The catch is that this was a study in healthy adults experiencing mild stress, not in people with diagnosed anxiety disorders. Extrapolating from lab-induced stress to chronic clinical anxiety is a stretch. L-theanine is generally safe and inexpensive, but treating it as a substitute for medication in significant anxiety would be a mistake.

Probiotics are another area of growing interest. Changes in gut bacteria can affect brain function through what researchers call the gut-brain axis, and a comprehensive review of clinical trials from 2014 to 2023 found that the majority of recent literature suggests a beneficial role of probiotics in treating depression and anxiety, though a substantial number of studies showed less positive results.¹⁴ The field is promising but inconsistent. No one can yet tell you which probiotic strain, at what dose, for how long, will reliably reduce anxiety. If you want to try a probiotic for mood support, it’s reasonable as an add-on, but it shouldn’t replace evidence-based treatment for clinically significant symptoms.

Why Medication Works Better with Therapy

A pattern that comes up repeatedly in the research is that medication and cognitive-behavioral therapy together outperform either one alone. A controlled trial comparing medication-only treatment to medication plus group cognitive-behavioral therapy for panic disorder found that the combination was significantly more effective.¹⁵ This makes intuitive sense for overthinking specifically. A pill can reduce the intensity of rumination by adjusting brain chemistry, but it doesn’t teach you to recognize when you’ve slipped into a worry loop, challenge the thoughts driving it, or build new habits around how you respond to uncertainty. Therapy addresses those skills directly.

For many people, medication creates the mental breathing room needed to actually engage with therapy. When your brain is running at full speed through catastrophic scenarios, sitting down to practice structured thought exercises can feel impossible. Once medication takes the edge off, therapy techniques become more accessible, and the two treatments reinforce each other. If you’re considering medication for overthinking, it’s worth asking your prescriber about a therapy referral at the same time, even if you start with medication first.

Stopping Medication and What to Expect

One concern that keeps people from starting medication in the first place is the fear of being stuck on it forever or going through a terrible withdrawal. The withdrawal issue is real but manageable. Antidepressant discontinuation syndrome occurs in at least 20% of patients who abruptly stop an antidepressant after taking it for six weeks or longer. Symptoms, which can include flu-like feelings, insomnia, nausea, and a rebound of anxiety, typically last two to six weeks.¹⁶ The key word there is “abruptly.” When you taper off gradually under a doctor’s guidance, the risk and severity of discontinuation symptoms drop considerably.

Whether you’ll need medication long-term depends on your situation. Some people take an SSRI for a year, combine it with therapy, build coping skills, taper off, and do well without it. Others find that their anxiety is a chronic condition that benefits from ongoing treatment, much like someone with high blood pressure might stay on medication indefinitely. Neither outcome is a failure. The decision about when and whether to stop should be made collaboratively with your prescriber, ideally during a period of sustained stability rather than in the middle of a crisis.

Pharmacogenomic Testing

You may have heard of genetic tests that claim to predict which psychiatric medication will work best for you. These pharmacogenomic panels, such as the GeneSight test, analyze genes involved in how your body metabolizes drugs. The test covers genes like CYP2D6 and CYP2C19, which influence how quickly your liver breaks down many common psychiatric medications, and generates a report that categorizes drugs as likely to work normally, require dose adjustments, or pose problems.¹⁷

The idea is appealing, especially if you’ve already tried one or two medications that didn’t work or caused bad side effects. In practice, these tests are more useful for flagging metabolic problems than for predicting therapeutic success. If you’re a rapid metabolizer of a particular drug, you might clear it from your system before it can work, and the test can catch that. But the genes tested don’t capture everything that determines whether a drug will reduce your anxiety. Brain chemistry, life circumstances, sleep, stress levels, and factors science hasn’t pinned down yet all play a role. Pharmacogenomic testing is a useful tool in the toolbox, particularly after a medication failure, but it’s not a crystal ball.

The Overthinking-Sleep Cycle

If you’ve ever lain awake at 2 a.m. trapped in a loop of anxious thoughts, you’ve experienced one of the most frustrating features of overthinking: it sabotages sleep, and poor sleep makes the overthinking worse. Researchers have proposed a framework in which sleep deprivation impairs the brain’s top-down inhibitory control networks, the systems responsible for suppressing unwanted thoughts. Once those controls weaken, intrusive thoughts increase, which leads to more emotional dysregulation, which further disrupts sleep, creating a vicious cycle.¹⁸

This cycle has practical implications for treatment. If medication reduces your daytime anxiety but you’re still sleeping poorly, the overnight rebound of ruminative thinking can undermine the benefit. Some prescribers choose medications partly based on their sedating properties for this reason: hydroxyzine or a sedating antidepressant like mirtazapine taken at night can pull double duty, reducing anxiety and improving sleep. Others address sleep separately with behavioral strategies or a short course of a sleep aid. Either way, if you’re seeking medication for overthinking, it’s worth telling your doctor specifically about your sleep. The two problems are connected enough that treating one without acknowledging the other often leaves you half-helped.

Placebo effects also play a measurable role in anxiety treatment that’s worth knowing about. Research into placebo mechanisms has identified involvement of pain-modulating brain networks, endogenous opioid pathways, and psychological processes like patient expectations and therapeutic engagement.¹⁹ In anxiety trials, placebo response rates frequently run above 30%, which is not evidence that the condition is imaginary. It means that the act of seeking treatment, believing you have support, and following a routine can itself shift brain chemistry in helpful directions. Medication adds measurably on top of that placebo response, but the response rate reminds us that context, hope, and the therapeutic relationship are not just feel-good additions to treatment. They are biologically active ingredients.